Biographical Sketch
Karl Theil, MD, serves in the Section of Hematopathology to provide diagnostic services in hematopathology, hemostasis and thrombosis, and cytogenetics.
He is certified by the American Board of Pathology in anatomic and clinical pathology, with special qualification in hematology.
He also serves as Director of the Pathology Residency Program at Cleveland Clinic.
Specialty Interests
hematopathology, leukemia, cytogenetics
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 7/30/2008,
Dr. Theil has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
